{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:08:27Z","timestamp":1793113707411,"version":"4.5.0"},"reference-count":28,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["71804093"],"award-info":[{"award-number":["71804093"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Ment Health"],"accepted":{"date-parts":[[2023,5,19]]},"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The association between antipsychotics and cardiovascular diseases (CVDs) remains significant yet unestablished, especially in Chinese populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the risk of CVDs associated with antipsychotics among Chinese individuals with schizophrenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a nested case\u2013control study on individuals diagnosed with schizophrenia in Shandong, China. The case group included individuals diagnosed with incident CVDs between 2012 and 2020. Each case was randomly matched with up to three controls. We used weighted logistic regression models to assess the risk of CVDs associated with antipsychotics and restricted cubic spline analysis to explore the dose\u2013response relationship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>In total, 2493 cases and 7478 matched controls were included in the analysis. Compared with non-users, any antipsychotics use was associated with higher risk of any CVDs (weighted OR=1.54, 95%\u2009CI 1.32 to 1.79), with the risk mainly driven by ischaemic heart diseases (weighted OR=2.26, 95%\u2009CI 1.71 to 2.99). Treatments with haloperidol, aripiprazole, quetiapine, olanzapine, risperidone, sulpiride and chlorpromazine were associated with increased risk of CVDs. A non-linear dose\u2013response relationship between dosage of antipsychotics and risk of CVDs was observed, with a sharp increase in risk in the beginning and then flattening out with higher doses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Use of antipsychotics was associated with increased risk of incident CVDs among individuals with schizophrenia, and the risk varied substantially among different antipsychotics and specific CVDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical implications<\/jats:title>\n                    <jats:p>Clinicians should consider the cardiovascular risk of antipsychotics and choose the appropriate type and dose of drugs in the treatment of schizophrenia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjment-2022-300501","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T13:20:52Z","timestamp":1686230452000},"page":"e300501","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Associations between antipsychotics and the risk of incident cardiovascular diseases in individuals with schizophrenia: a nested case\u2013control study"],"prefix":"10.1136","volume":"26","author":[{"given":"Peng","family":"Peng","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China"},{"name":"Center for Big Data Research in Health and Medicine, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiqing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Public Health, Weifang Medical University, Weifang, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhuo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China"},{"name":"Center for Big Data Research in Health and Medicine, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China"},{"name":"Center for Big Data Research in Health and Medicine, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Ji","sequence":"additional","affiliation":[{"name":"School of Public Health, Weifang Medical University, Weifang, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihua","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4969-2135","authenticated-orcid":false,"given":"Fang","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China"},{"name":"Shandong Provincial Qianfoshan Hospital, Shandong University Cheeloo College of Medicine, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"2025082703192989000_26.1.e300501.1","first-page":"573","article-title":"Report on cardiovascular health and diseases in China 2021: an updated summary","volume":"35","year":"2022","journal-title":"Biomed Environ Sci"},{"key":"2025082703192989000_26.1.e300501.2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/schbul\/sbaa137","article-title":"Excess mortality and life-years lost in people with schizophrenia and other non-affective psychoses: an 11-year population-based cohort study","volume":"47","author":"Yung","year":"2021","journal-title":"Schizophr Bull"},{"key":"2025082703192989000_26.1.e300501.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-00463-7"},{"key":"2025082703192989000_26.1.e300501.4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ajp.2015.11.012","article-title":"Cardiovascular diseases among patients with schizophrenia","volume":"19","author":"Azad","year":"2016","journal-title":"Asian J Psychiatr"},{"key":"2025082703192989000_26.1.e300501.5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.psychres.2018.04.020","article-title":"10-year CVD risk in Han Chinese mainland patients with schizophrenia","volume":"264","author":"Zhao","year":"2018","journal-title":"Psychiatry Res"},{"key":"2025082703192989000_26.1.e300501.6","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20420"},{"key":"2025082703192989000_26.1.e300501.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01730-X"},{"key":"2025082703192989000_26.1.e300501.8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.10081224"},{"key":"2025082703192989000_26.1.e300501.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.008779"},{"key":"2025082703192989000_26.1.e300501.10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijcard.2016.11.185","article-title":"Antipsychotic treatment is associated with risk of atrial fibrillation: a nationwide nested case-control study","volume":"227","author":"Chou","year":"2017","journal-title":"Int J Cardiol"},{"key":"2025082703192989000_26.1.e300501.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2011.03479.x"},{"key":"2025082703192989000_26.1.e300501.12","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/schbul\/sbab078","article-title":"Examining side effect variability of antipsychotic treatment in schizophrenia spectrum disorders: a meta-analysis of variance","volume":"47","author":"Neumeier","year":"2021","journal-title":"Schizophr Bull"},{"key":"2025082703192989000_26.1.e300501.13","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30416-X"},{"key":"2025082703192989000_26.1.e300501.14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/appi.ajp.2018.17091001","article-title":"20-year nationwide follow-up study on discontinuation of antipsychotic treatment in first-episode schizophrenia","volume":"175","author":"Tiihonen","year":"2018","journal-title":"Am J Psychiatry"},{"key":"2025082703192989000_26.1.e300501.15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/wps.20994","article-title":"Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors","volume":"21","author":"Correll","year":"2022","journal-title":"World Psychiatry"},{"key":"2025082703192989000_26.1.e300501.16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2022.05.014","article-title":"The antipsychotic paradox: lessons regarding determinants of premature mortality","volume":"62","author":"Solmi","year":"2022","journal-title":"Eur Neuropsychopharmacol"},{"key":"2025082703192989000_26.1.e300501.17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/schbul\/sbab087","article-title":"Antipsychotics use is associated with greater adherence to cardiometabolic medications in patients with schizophrenia: results from a nationwide, within-subject design study","volume":"48","author":"Solmi","year":"2022","journal-title":"Schizophr Bull"},{"key":"2025082703192989000_26.1.e300501.18","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20222"},{"key":"2025082703192989000_26.1.e300501.19","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-018-0119-4"},{"key":"2025082703192989000_26.1.e300501.20","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.11.08010","article-title":"Infectious diseases among elderly persons: results from a population-based observational study in Shandong province","volume":"11","author":"Du","year":"2021","journal-title":"J Glob Health"},{"key":"2025082703192989000_26.1.e300501.21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cac2.12242","article-title":"Association between antipsychotic agents and risk of lung cancer: a nested case-control study","volume":"42","author":"Li","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"2025082703192989000_26.1.e300501.22","unstructured":"Guideline of national essential public health services 2011 version. 2011. Available: http:\/\/www.nhc.gov.cn\/jws\/s3578\/201703\/d20c37e23e1f4c7db7b8e25f34473e1b.shtml [Accessed 20 Jan 2022]."},{"key":"2025082703192989000_26.1.e300501.23","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.2016.1260466"},{"key":"2025082703192989000_26.1.e300501.24","unstructured":"ICD-10 version:2019. Available: https:\/\/icd.who.int\/browse10\/2019\/en#\/IX [Accessed 20 Jan 2022]."},{"key":"2025082703192989000_26.1.e300501.25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.vph.2017.09.001","article-title":"Effects of psychopharmacological treatment with antipsychotic drugs on the vascular system","volume":"100","author":"Kahl","year":"2018","journal-title":"Vascul Pharmacol"},{"key":"2025082703192989000_26.1.e300501.26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/ijnp\/pyz068","article-title":"Antipsychotic polypharmacy: a dirty little secret or a fashion","volume":"23","author":"Lin","year":"2020","journal-title":"Int J Neuropsychopharmacol"},{"key":"2025082703192989000_26.1.e300501.27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/wps.21036","article-title":"Metabolic side effects in persons with schizophrenia during mid- to long-term treatment with antipsychotics: a network meta-analysis of randomized controlled trials","volume":"22","author":"Burschinski","year":"2023","journal-title":"World Psychiatry"},{"key":"2025082703192989000_26.1.e300501.28","unstructured":"Shu L , Si TM . Guideline for schizophrenia. Beijing: Beijing University, 2007."}],"container-title":["BMJ Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjment-2022-300501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:19:40Z","timestamp":1756289980000},"score":1,"resource":{"primary":{"URL":"https:\/\/mentalhealth.bmj.com\/lookup\/doi\/10.1136\/bmjment-2022-300501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,6,8]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1136\/bmjment-2022-300501"],"URL":"https:\/\/doi.org\/10.1136\/bmjment-2022-300501","relation":{},"ISSN":["2755-9734"],"issn-type":[{"value":"2755-9734","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}